Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q39375855)
Watch
English
Acquired resistance to BRAF inhibition can confer cross-resistance to combined BRAF/MEK inhibition.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22437314
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437314%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 January 2020
title
Acquired resistance to BRAF inhibition can confer cross-resistance to combined BRAF/MEK inhibition
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22437314
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437314%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 January 2020
main subject
cell line
0 references
author
Therese Becker
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22437314
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437314%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 January 2020
Richard F. Kefford
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22437314
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437314%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 January 2020
author name string
Kavitha Gowrishankar
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22437314
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437314%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 January 2020
Stephanie Snoyman
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22437314
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437314%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 January 2020
Gulietta M Pupo
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22437314
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437314%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 January 2020
Helen Rizos
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22437314
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437314%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 January 2020
language of work or name
English
0 references
publication date
22 March 2012
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22437314
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437314%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 January 2020
published in
Journal of Investigative Dermatology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22437314
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437314%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 January 2020
volume
132
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22437314
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437314%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 January 2020
issue
7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22437314
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437314%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 January 2020
page(s)
1850-1859
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22437314
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437314%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 January 2020
describes a project that uses
Mel-RMu/DR2
0 references
Mel-RMu/DR4
0 references
Mel-RMu/DR6
0 references
Mel-RMu/DR8
0 references
Mel-RMu/DR9
0 references
exact match
https://scigraph.springernature.com/pub.10.1038/jid.2012.63
0 references
cites work
Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
BRAF gene amplification can promote acquired resistance to MEK inhibitors in cancer cells harboring the BRAF V600E mutation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mutations of the BRAF gene in human cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
MEK1 mutations confer resistance to MEK and B-RAF inhibition
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enforced expression of p14ARF induces p53-dependent cell cycle arrest but not apoptosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oncogene-induced senescence does not require the p16(INK4a) or p14ARF melanoma tumor suppressors.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I/II study to assess safety, pharmacokinetics, and efficacy of the oral MEK 1/2 inhibitor GSK1120212 (GSK212) dosed in combination with the oral BRAF inhibitor GSK2118436 (GSK436)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined targeting of BRAF and CRAF or BRAF and PI3K effector pathways is required for efficacy in NRAS mutant tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
MEK-independent survival of B-RAFV600E melanoma cells selected for resistance to apoptosis induced by the RAF inhibitor PLX4720.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Elevated CRAF as a potential mechanism of acquired resistance to BRAF inhibition in melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The "SWOT" of BRAF inhibition in melanoma: RAF inhibitors, MEK inhibitors or both?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dual inhibition of (V600E)BRAF and the PI3K/AKT/mTOR pathway cooperates to induce apoptosis in melanoma cells through a MEK-independent mechanism
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
IGFBP7 is not required for B-RAF-induced melanocyte senescence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combinatorial treatments that overcome PDGFRβ-driven resistance of melanoma cells to V600EB-RAF inhibition
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Understanding melanoma signaling networks as the basis for molecular targeted therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
BRAF mutation predicts sensitivity to MEK inhibition
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The mammalian MAPK/ERK pathway exhibits properties of a negative feedback amplifier
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comprehensive dissection of PDGF-PDGFR signaling pathways in PDGFR genetically defined cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2012.63
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1038/JID.2012.63
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22437314
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437314%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 January 2020
PubMed publication ID
22437314
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22437314
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22437314%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 January 2020
ResearchGate publication ID
221903892
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit